The TSB BioBank, under our umbrella protocol, provides high-quality human tissues, blood, and other biospecimens that are prospectively collected, processed, and stored for distribution to investigators, with or without their own IRB protocol, in accordance with procedures that comply with the confidentiality, safety and all other regulatory standards set by UW-Madison and the National Cancer Institute’s Best Practices for Biospecimen Resources.
Please see BioBank Re-Opening Policies for information on our operations in the current UW Research Reboot phase.
In an effort to mobilize research efforts in support of SARS-CoV-2 (COVID-19) related research, the UWCCC BioBank, in conjunction with the School of Medicine and Public Health Dean’s Office, has expanded its strategic approach by: 1) collecting remnant biospecimens (nasopharyngreal swabs/serum/plasma/whole blood) from patients under investigation, known COVID-19 positive patients and patients who have recovered from COVID-19 infection, 2) developing a streamlined process to efficiently submit/review/approve research proposals and distribute clinically-annotated biospecimens, and 3) providing investigators access to samples and/or clinical and survey data from other IRB-approved resources like the UW Survey of the Health of Wisconsin (SHOW) and from our affiliate institutions.
The ability of the BioBank to mobilize these COVID-19 research efforts is based on leveraging established relationships with outstanding colleagues and departments including the Department of Pathology & Laboratory Medicine, the Institutional Review Board (IRB), the Institute for Institute of Clinical and Translational Research (ICTR) and the UW School of Medicine and Public Health (SMPH). Funding for this project was provided by the UW School of Medicine and Public Health from the Wisconsin Partnership Program through a grant to the UW Institute for Clinical and Translational Research.
Due to anticipated high demand, the SMPH’s oﬃce of Basic Research is calling for research proposals that utilize the UWCCC BioBank’s resources to further COVID-19 research eﬀorts.
Additional information and application instructions can be found in the RFA online here.
As of October 9th 2020, we have collected blood products from >90 COVID+, >70 negative and >115 COVID convalescent consented patients, including samples across multiple time points for a subset of those patients. Positive and negative nasopharyngeal swab remnants are also available. For further details on inventory, please contact the BioBank Email.
Flash frozen, cryopreserved, formalin-fixed and paraffin embedded, and OCT embedded biospecimens
Chart review for PRMC and IRB approved protocols
Customized Biospecimen Acquisition
For PRMC and IRB-approved protocols
Pathology Slide Review
- H&E stained slide interpretation
- Interpret IHC slides in conjunction with H&E
- Evaluate IHC staining for antibody optimization (per antibody)
Nucleic Acid Analysis (Bioanalyzer)
The Bioanalyzer is a chip-based capillary electrophoresis machine to analyze RNA and DNA. Used as a quality control mechanism prior to downstream experiments.
Tissue Microarrays (TMA) in cooperation with the Translational Research Initiatives in Pathology (TRIP) lab
Contact us for current inventory, distribution or questions.
Email the Biobank to reserve the Bioanalyzer, Cryostat, Microtome, or Vibratome.
It has been estimated that 18-36% of cell lines utilized in biomedical research are contaminated and/or completely misidentified. Verification of human and stem cell line identity is critical to the validity of the scientific data. …August 14, 2019
We are happy to announce the new UW iLab Core Facility Management website! The iLab core management application is a web-based solution designed to streamline core facility management through assisting managers with their billing, invoicing, reservation …April 19, 2019
Any published research which received funding from the UWCCC Cancer Center Support Grant (CCSG), including the use of UWCCC Shared Resources to generate or analyze data or conduct clinical trials, must acknowledge the UWCCC. See Acknowledging UWCCC in Publications, Posters, and Presentations. Please also acknowledge “UWCCC TSB-BioBank” for any work supported by the BioBank. Thank you!
Click the link above to view and review the steps required to request biospecimens from the TSB BioBank Biospecimen Inventory and TMA inventory for studies (including pilot studies), with IRB approval, or without IRB approval.
Click the link above to find more information on the UWCCC Translational Science BioCore (TSB BioBank) Fee Schedule. Please note, the TMA charges are listed in the descriptions for each TMA, which are specific to disease site.
*Users can now pay by credit card using our online bill pay option.